Search for: "IN RE WYETH"
Results 301 - 320
of 702
Sorted by Relevance
|
Sort by Date
8 Oct 2009, 8:41 pm
In re Diet Drugs (Fenfluramine/Phentermine/Dexenfluramine) Product Liability Litig., No. 08-2363 (3d Cir. [read post]
2 Jun 2008, 5:00 am
Supreme Court -- will be deciding the preemption issue in Wyeth v. [read post]
16 May 2012, 12:22 pm
Wyeth LLC, ___ F. [read post]
17 Dec 2009, 11:22 am
Wyeth v. [read post]
2 Oct 2014, 9:18 am
”That’s bad if you’re representing OTC drug manufacturers, as we sometimes do. [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
23 Mar 2012, 1:29 pm
Wyeth Pharmaceuticals, No. [read post]
23 Aug 2011, 2:46 pm
” In re Morgan, 990 F.2d 1230, 1232 (Fed. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
21 Jun 2010, 1:22 pm
The case of Wyeth LLC te al., v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
12 Feb 2009, 1:49 pm
No, says Doug Petkus, a Wyeth Pharmaceuticals spokesman. [read post]
16 Nov 2011, 5:43 pm
And the Court distinguished its decision from Wyeth v. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
29 Dec 2011, 6:53 am
Wyeth LLC, 131 S. [read post]
1 Jun 2010, 11:37 am
The lower courts’ reaction to Wyeth v. [read post]
3 Jun 2010, 5:35 am
(Spicy IP) Wellbutrin (Bupropion) – US: Pennsylvania District Court decision signals a new turn in the generic drug preemption debate; a tough pill to swallow for the generic industry: In re Budeprion XL Marketing & Sales Litigation (FDA Law Blog) [read post]
7 Aug 2007, 8:12 am
Wyeth Labs., 510 F. [read post]
3 Nov 2010, 4:30 am
It will be very interesting to see if, in the wake of Wyeth v. [read post]
